Sex Therapists Reveal The 7 Essential Post-Sex Habits You Should Never Skip
By doing just a few essential things right after you enjoy your partner, you can extend intimacy and promote optimum sexual well-being. Below are a few expert-backed activities you should consider right after every romp for your own health:
Hit the bathroom.
What everyone hears about peeing after sex is true, said Sunny Rodgers, a certified sex coach and ambassador for the American Sexual Health Association. It's a necessity.
'This is the first step I always suggest for right after sex,' Rodgers explained. 'This 'clears the pipes' and can help dispel any bacteria or toxins.' Afterward, Rodgers said you might want to briefly wash up, 'using a clean washcloth, gentle unscented soap and warm water.'
This essential hygiene step will do a lot to ensure comfort and help protect against infections, like painful UTIs, Rodgers said. An added PSA: Also remember to wash from front to back.
Choose breathable underwear.
Next, Rodgers suggested selecting breathable underwear from your drawer.
'Cotton is the best for allowing genitals to breathe,' she explained. 'Being a natural fiber, cotton is also hypoallergenic, highly absorbent, and won't irritate your most sensitive regions ― which are prone to heightened sensitivity and moisture after sex.'
Cuddle up.
There's a reason pillow talk is so satisfying ― you're primed for bonding. Each time you have sex with a partner, 'the love hormone,' scientifically known as oxytocin, is released.
'This hormone creates a feeling of closeness,' said Chamin Ajjan, a New York City-based psychotherapist and sex therapist. 'Talking with your partner after sex is a great way to connect and create even more intimacy. You can talk about your hopes, your dreams, what you would like to do with your partner, or anything that is important to you.'
Hydrate.
Either grab a bottle of water from the fridge and put it on your nightstand before you have sex, or make sure to hit the kitchen just after.
'Drinking a minimum of eight ounces of water after sex play can help you hydrate and keep your energy levels up, since sexual stimulation can definitely deplete strength,' Rodgers said. 'It can also help flush out bacteria from urinary tracts.' Sip up.
Grab a snack.
It's not unheard of to feel hungry after sex, because you burn calories and get your heart rate up. Grab a snack after, like chia seeds or green tea, Rodgers suggested. Or, you can try one of these post-burn foods.
You can also consider cooking something simple but satisfying together, like an omelette, Ajjan said. It's a great way to continue bonding and use more teamwork and communication.
Compliment each other.
In order to get the most out of future sexual encounters, it's important to verbalize what you liked with your partner.
'Immediately after sex, oxytocin is still high,' said Karla Ivankovich, a couples therapist and clinical counselor at OnePatient Global Health. 'Share with one another what it is that you really enjoyed about your intimacy, physically or emotionally, is a great way to keep bonding.'
Even if you didn't reach orgasm, connecting on an emotional level and communicating with each other allows for 'everyone's needs to be met,' explained Ivankovich.
Laugh.
Right after sex, you can also keep yourself in a playful mindset and connect with a bit of humor.
'In the post-coital state of euphoria, everything seems better anyway,' Ivankovich said. 'Tell a corny joke, be silly, and extend the time in intimacy. That extra time is important; if one partner leaves too quickly, someone feels like their high just crashed to the bottoms.'
Overall, try not to think of sex as a just one-act play. It should also revolve around relaxing together, prolonging intimacy, and taking care of your health, too.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Chicago Tribune
5 hours ago
- Chicago Tribune
Funding cuts ripple across Northwestern, as faculty urge no deal with Trump
Nearly four months have passed since the Donald Trump administration abruptly froze $790 million in federal funding at Northwestern University, and the school's fragile research infrastructure has been pummeled by cuts. Portions of research and clinical trials have ground to a halt. Labs have been instructed to scrutinize every expense, from equipment to personnel. Some teams are even killing off lab mice because it's cheaper than feeding them and cleaning cages. With university President Michael Schill set to appear again before a congressional committee Tuesday, rumors of a possible deal with the White House have gripped campus. But the situation on-the-ground remains dire, according to faculty and staff. 'Let's say they unfreeze the funds. The damage is done,' said Guillermo Oliver, a professor in the Division of Nephrology and Hypertension. 'Let's be clear, this is not going to be, 'OK, back to business.'' Northwestern never received formal notification of the funding freeze in April, which came amid several federal probes into allegations of antisemitism. The Evanston-based university has been spending about $10 million a week to keep research afloat, faculty told the Tribune in June. That's led officials to pursue a string of belt-tightening measures. Last week, the university eliminated more than 400 positions, half of which were already vacant. A month earlier, officials announced changes to employees' health insurance plans and a hiring freeze. While Northwestern pays out-of-pocket for research, departments have urged scientists to crimp spending. The Feinberg School of Medicine, which receives 70% of the university's research funding, has seen the brunt of those cuts — potentially putting lifesaving work at risk, faculty say. The Oliver Lab at Feinberg studies the biological development of the lymphatic system. Each piecemeal reduction has contributed to an environment of uncertainty among its staff. As the freeze drags on, Oliver isn't sure how long he can maintain bare-bones operations. 'We were asked to cut as many costs as we could, in everything,' Oliver said. 'The stressful question is, 'When will this be over?' We have no idea.' Many Northwestern scientists, including Oliver, utilize genetically engineered mice specifically bred for lab work. But animal costs have had to be reduced, too. 'It was not mandatory,' he said. 'Nobody told us, 'You need to reduce your mouse colony by 50%.' Rather it was, 'Try to reduce as much as you can without major impact to your research.'' Infrastructure for labs and clinical trials takes time to develop, and sudden shifts in resources and personnel can jeopardize years of work. That can't be immediately reversed, researchers say. Scott Budinger, chief of pulmonary and critical care in the department of medicine, has spent more than two decades researching drugs to treat pneumonia. While his team is still able to collect vital patient samples, they've been left untouched in a freezer. 'The work on those new drug targets has virtually stopped … All of that work could be gone in several months,' Budinger said. 'If we start to lose the people and lose the expertise, you can't just step in and rebuild that work.' It's unclear how much longer Northwestern can continue to fund research without reimbursement. A university spokesperson did not respond to requests for comment. Northwestern is among the wealthiest universities in the country, with a $14.3 billion endowment. But the school's business model was built on grants: During its 2023-24 fiscal year, it received $1.05 billion in research funding. Amid the pause, the endowment and donors can only offer so much support. Endowments weren't designed to be rainy-day funds or sitting cash. A large portion of the capital is invested in hedge funds and private equity. Much of the pool is also restricted, meaning the funds are reserved by donors for specific purposes — such as scholarships or academic programs. In a typical year, most universities only draw from their year-to-year earnings at a rate of less than 5% of the total endowment. That uncertainty — coupled with perceived threats to academic freedom — has led some scientists to explore opportunities elsewhere, even outside of the U.S. Faculty members have voiced concerns that a potential exodus of researchers could undermine Northwestern's competitiveness on the global stage. It's an option weighed by Benjamin Thomson, an assistant professor of ophthalmology who said he would consider returning to his home country of Canada. 'I've done some looking at positions,' Thomson said. 'I have no immediate intention of leaving, but it's not something I would necessarily be averse to if the situation were different.' In recent weeks, several Ivy League schools have settled with the Trump administration to restore paused funding. Columbia University, for example, will pay more than $220 million to the federal government and implement several initiatives aimed at addressing antisemitism on campus. The Wall Street Journal reported that Northwestern officials were also in talks with White House. A university spokesperson declined to comment, but rumors of a deal have already rippled through campus. Northwestern's Concerned Faculty Group, which represents hundreds of members, said in a statement last week that a settlement would make the school 'complicit in an assault on institutions of higher education.' The Trump administration has leveraged federal funding to force universities to comply with its agenda, the statement said. 'This is extortion,' said Laura Beth Nielsen, a professor of sociology and member of the group. 'We need to resolve the situation, but not at the expense of academic freedom.' Meanwhile, Schill is set to appear again before the House Committee on Education and the Workforce in a transcribed interview closed to the press Tuesday. When he last appeared before the Republican-led body in May 2024, he was grilled for hours about the campus environment for Jewish students. A committee spokesperson did not directly comment on when or if the transcription might be made public. 'We all agree that if there is an antisemitism problem on campus, that the university is under an obligation to take action to stop it,' said Paul Gowder, a professor of law. 'But we also all agree that this is a pretext.' The situation has left some faculty conflicted. Many are alarmed by the prospect of yielding to federal pressure, but also recognize that an indefinite funding freeze poses serious risks. Melissa Simon, vice chair for research in the department of general obstetrics and gynecology, was one of the highest-funded Northwestern professors through the National Institutes of Health. In May, her research hub, the Center for Health Equity Transformation, was shuttered with just minutes' notice. Simon suspects Northwestern closed the lab to comply with the Trump administration's crackdown on diversity, equity and inclusion initiatives. A few weeks later, she was allowed to resume the center's research under a new name, Elevate Lab. But the whiplash has been draining. 'I'm fighting every day. It has been demoralizing and exhausting,' Simon said. 'But how much will so-called negotiation with Trump help?' Last week, Simon was forced to lay off her program assistant, Chisom Chima, her only staffer not funded by grant money. Both women were devastated. 'It's very heartbreaking, not just to lose a job, but to lose a job working with this team,' Chima said. 'Everyone has been on edge.' Next month, undergraduate students will begin to trickle back to campus. It won't be a typical academic year. When Schill announced the layoffs last week, he called the period of the freeze 'among the most difficult in our institution's 174-year history.' But the message among faculty is clear: The university is at a tipping point for research. 'I think if the freeze were reversed today, we could get things back,' Budinger said. 'I don't think it's too late yet, but time is running out.'
Miami Herald
7 hours ago
- Miami Herald
enVVeno Medical Participates in a New Virtual Investor "What This Means" Segment to Discuss How President Trump's Recent CVI Diagnosis May Impact the Company
- enVVeno is developing the VenoValve as a potential treatment option for the approximately 2.5 million patients in the U.S. suffering from severe deep Chronic Venous Insufficiency - FDA decision expected in 2H'2025 - Access the "What This Means" segment here IRVINE, CA / ACCESS Newswire / August 4, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno Medical" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that it participated in a Virtual Investor "What This Means" segment entitled, "enVVeno Medical - Making Veins Work Again - How President Trump's CVI Diagnosis is Raising Awareness." Rob Berman, CEO and Dr. Marc Glickman, CMO of enVVeno Medical discussed the progressive nature of chronic veinous insufficiency and whether President Trump may one day be a candidate for the VenoValve® following U.S. Food and Drug Administration (FDA) approval. The Company estimates that there are approximately 2.5 million patients in the U.S. that could be candidates for the VenoValve. The Company has submitted a pre-market authorization (PMA) application for the VenoValve to the FDA, with a decision anticipated in the second half of 2025. The "What This Means" segment can be accessed here. About CVI Severe deep venous CVI is a serious and debilitating disease that is most often caused by blood clots (deep vein thromboses or DVTs) in the deep veins of the leg. When valves inside of the veins of the leg fail, blood flows in the wrong direction and pools in the lower leg, causing pressure within the veins of the leg to increase (venous hypertension). Symptoms of CVI include leg swelling, pain, edema, and in the most severe cases, recurrent open sores known as venous ulcers. The disease can severely impact everyday functions such as sleeping, bathing, dressing, and walking, and is known to result in high rates of depression and anxiety. There are currently no effective treatments that repair deep venous valve dysfunction, the #1 cause of severe CVI-a disease estimated to cost the U.S. healthcare system in excess of $26 billion each year. About enVVeno Medical Corporation enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company's lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the VenoValve U.S. pivotal study and the Company is currently performing the final testing necessary to seek approval for the pivotal trial for enVVe. INVESTOR CONTACT: Jenene Thomas, JTC Team, LLCNVNO@ 824-0775 MEDIA CONTACT:Glenn Silver, FINN 818-8198 SOURCE: enVVeno Medical Corporation
Business Wire
9 hours ago
- Business Wire
Family Health Services of Darke County and AndHealth Celebrate Ribbon Cutting and Launch of Retail + Specialty Pharmacy at Expanded Greenville Location
GREENVILLE, Ohio--(BUSINESS WIRE)--Family Health Services of Darke County and AndHealth will celebrate the opening of Family Health Services' retail and specialty pharmacy on Thursday, August 7 th at 4:00 PM. The ribbon cutting will take place at Family Health Services' newly expanded Greenville facility, located at 5735 Meeker Road, and will be followed by an open house from 5:00 – 8:00 PM featuring light refreshments, family-friendly activities, and tours of the renovated space. "With this expansion, we're not just adding services, we're closing care gaps and removing barriers to health for our neighbors.' This milestone marks a major step forward in Family Health Services' mission of Building Healthy Lives Together. This expansion adds 44,000 square feet of clinical space, modernizes the patient experience, and introduces expanded pharmacy services, including the launch of Darke County's only specialty pharmacy. These enhancements will significantly improve access for patients managing chronic and complex conditions, particularly those impacted by long-standing pharmacy shortages in rural Ohio. Family Health Services' specialty pharmacy services are powered by a partnership with AndHealth, a Columbus-based healthcare company that helps CHCs radically improve access and outcomes to specialty care. Ohioans can now fill their prescriptions directly through Family Health Services' pharmacy, where affordable medications are available to all patients under Family Health Service's sliding fee scale. 'There is an immense value in having specialty care and pharmacy services directly within our community,' said Jared Polick, Executive Director and CEO of Family Health Services. 'Residents of Darke County will now be able to receive care close to home and have the personal support of local clinical pharmacists and specialists. With this expansion, we're not just adding services, we're closing care gaps and removing barriers to health for our neighbors.' The updated Greenville facility now offers integrated medical, behavioral health, dental, rheumatology, dermatology, neurology, and pharmacy services under one roof – creating a true whole-person care environment that prioritizes convenience, coordination, and affordability. Addressing Ohio's Pharmacy Deserts and Improving Medication Access According to new data 1 released by the Ohio Board of Pharmacy, pharmacy closures have accelerated, and the state has lost hundreds of pharmacies over the past several years, leaving Ohioans with less than 2,000 retail pharmacies. Nearly 2 million Ohioans live in 'pharmacy deserts', or areas that lack convenient access to a pharmacy. 2 These access deserts disproportionately impact individuals in socially vulnerable communities, who face additional barriers to access and care, making the role of pharmacies located at CHCs even more central to improving community health in Ohio. AndHealth partners with Community Health Centers (CHCs) like Family Health Services to expand access to care by addressing pharmacy and care deserts. 'Ensuring our patients have access to affordable medications can only be accomplished when we reverse the trend of pharmacy consolidation and closure,' said Brenda Reitz, Family Health Services' Pharmacy Director. 'This pharmacy expansion allows us to support the community in new ways and ensures our neighbors needs can be met right here in Darke County.' Family Health Services' ribbon cutting will take place at its 5935 Meeker Rd location in Greenville at 4:00 P.M. on August 7 th with an open house to follow from 5:00 – 8:00 PM. The event is open to all, and guests are encouraged to RSVP by contacting Kalie Riffle at kriffle@ About Family Health Services Family Health Services is a Federally Qualified Health Center (FQHC) dedicated to building healthier lives through integrated, affordable care. With locations across Darke County, FHS provides comprehensive services – including medical, dental, behavioral health, specialty care, and pharmacy – to patients of all ages, regardless of insurance status or ability to pay. To learn more, visit About AndHealth AndHealth helps Community Health Centers (CHCs) radically improve access and outcomes for patients in specialty care and specialty pharmacy, while becoming an even larger and more clinically integrated part of our healthcare system. This Whole-Person Community Care Model provides everything CHCs need to deliver in-house specialty care and specialty pharmacy, built for the unique needs of our medically underserved populations. The model provides CHCs with more patients, more clinical capabilities, alignment with health systems, and sustainable reimbursement and funding that restores the integrity of the patient's medical home and their critical reimbursement model—both having shifted away from CHCs through external specialty referrals and contract pharmacies. In restoring this integrity, CHCs can tear down barriers to care and stretch scarce federal resources to reach more patients with comprehensive services that weren't possible before and that are desperately needed by patients. Headquartered in Columbus, Ohio, AndHealth is led by former CoverMyMeds co-founder and CEO Matt Scantland and the team that built Ohio's first healthcare technology unicorn, who have dedicated their lives to transformative innovation that improves access for patients. AndHealth is supported by key investors including the American Medical Association's innovation subsidiary, Francisco Partners, and the state of Ohio's economic development organization. To learn more, visit
